Clinico-biological trajectories stratified by combined tau biomarkers in preclinical Alzheimer’s disease
Abstract Background Tau pathology biomarkers provide prognostic indicators of neurodegeneration and cognitive decline in Alzheimer’s disease (AD), making them crucial to early patient stratification for disease-modifying interventions. Plasma p-tau217 indexes early tau pathophysiology, whereas FDA/E...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2026-06-01
|
| Серія: | Alzheimer’s Research & Therapy |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s13195-026-02123-3 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|